Prostaglandin E2 inhibits in-vitro mineral deposition by human periodontal ligament cells via modulating the expression of TWIST1 and RUNX2. (Q50481139)

From Wikidata

Jump to navigation Jump to search

scientific article published on 11 January 2014

Language	Label	Description	Also known as
English	Prostaglandin E2 inhibits in-vitro mineral deposition by human periodontal ligament cells via modulating the expression of TWIST1 and RUNX2.	scientific article published on 11 January 2014

Statements

scholarly article

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/24410709

Prostaglandin E2 inhibits in-vitro mineral deposition by human periodontal ligament cells via modulating the expression of TWIST1 and RUNX2. (English)

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/24410709

prostaglandin E2

1 reference

based on heuristic

inferred from title

author name string

J Manokawinchoke

1

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/24410709

A Pimkhaokhum

2

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/24410709

V Everts

3

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/24410709

P Pavasant

4

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/24410709

publication date

11 January 2014

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/24410709

Journal of Periodontal Research

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/24410709

49

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/24410709

6

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/24410709

777-784

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/24410709

Role of PGE2 and EP receptors in the pathogenesis of rheumatoid arthritis and as a novel therapeutic strategy.

1 reference

https://api.crossref.org/works/10.1111%2FJRE.12162

21 January 2018

Regulation of immune responses by prostaglandin E2

1 reference

https://api.crossref.org/works/10.1111%2FJRE.12162

21 January 2018

Prostaglandin E2 inhibits alveolar macrophage phagocytosis through an E-prostanoid 2 receptor-mediated increase in intracellular cyclic AMP.

1 reference

https://api.crossref.org/works/10.1111%2FJRE.12162

21 January 2018

Prostaglandin E(2) inhibits collagen expression and proliferation in patient-derived normal lung fibroblasts via E prostanoid 2 receptor and cAMP signaling.

1 reference

https://api.crossref.org/works/10.1111%2FJRE.12162

21 January 2018

Prostaglandin E2 inhibits fibroblast to myofibroblast transition via E. prostanoid receptor 2 signaling and cyclic adenosine monophosphate elevation.

1 reference

https://api.crossref.org/works/10.1111%2FJRE.12162

21 January 2018

Prostaglandin E(2) inhibits fibroblast migration by E-prostanoid 2 receptor-mediated increase in PTEN activity

1 reference

https://api.crossref.org/works/10.1111%2FJRE.12162

21 January 2018

Osteoclast differentiation and activation

1 reference

https://api.crossref.org/works/10.1111%2FJRE.12162

21 January 2018

Effects of arachidonic acid and docosahexaenoic acid on differentiation and mineralization of MC3T3-E1 osteoblast-like cells

1 reference

https://api.crossref.org/works/10.1111%2FJRE.12162

21 January 2018

EP2 and EP4 receptors differentially mediate MAPK pathways underlying anabolic actions of prostaglandin E2 on bone formation in rat calvaria cell cultures

1 reference

https://api.crossref.org/works/10.1111%2FJRE.12162

21 January 2018

Prostanoid receptors: subtypes and signaling

1 reference

https://api.crossref.org/works/10.1111%2FJRE.12162

21 January 2018

Effects of selective prostaglandins E2 receptor agonists on cultured calvarial murine osteoblastic cells

1 reference

https://api.crossref.org/works/10.1111%2FJRE.12162

21 January 2018

An EP2 receptor-selective prostaglandin E 2 agonist induces bone healing

1 reference

https://api.crossref.org/works/10.1111%2FJRE.12162

21 January 2018

Effects of selective prostaglandin EP2 and EP4 receptor agonists on bone resorption and formation in fetal rat organ cultures

1 reference

https://api.crossref.org/works/10.1111%2FJRE.12162

21 January 2018

BMP-2 mediates PGE(2) -induced reduction of proliferation and osteogenic differentiation of human tendon stem cells

1 reference

https://api.crossref.org/works/10.1111%2FJRE.12162

21 January 2018

Systemic prostaglandin E2 increases cancellous bone formation and mass in aging rats and stimulates their bone marrow osteogenic capacity in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1111%2FJRE.12162

21 January 2018

Prostaglandin E(2) receptors in bone formation

1 reference

https://api.crossref.org/works/10.1111%2FJRE.12162

21 January 2018

Prostaglandin E2 receptor (EP4) selective agonist (ONO-4819.CD) accelerates bone repair of femoral cortex after drill-hole injury associated with local upregulation of bone turnover in mature rats

1 reference

https://api.crossref.org/works/10.1111%2FJRE.12162

21 January 2018

Stimulation of bone formation and prevention of bone loss by prostaglandin E EP4 receptor activation

1 reference

https://api.crossref.org/works/10.1111%2FJRE.12162

21 January 2018

Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts

1 reference

https://api.crossref.org/works/10.1111%2FJRE.12162

21 January 2018

Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development

1 reference

https://api.crossref.org/works/10.1111%2FJRE.12162

21 January 2018

A twist code determines the onset of osteoblast differentiation

1 reference

https://api.crossref.org/works/10.1111%2FJRE.12162

21 January 2018

TWIST inactivation reduces CBFA1/RUNX2 expression and DNA binding to the osteocalcin promoter in osteoblasts

1 reference

https://api.crossref.org/works/10.1111%2FJRE.12162

21 January 2018

Mutations of the TWIST gene in the Saethre-Chotzen syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJRE.12162

21 January 2018

Mutations in TWIST, a basic helix-loop-helix transcription factor, in Saethre-Chotzen syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJRE.12162

21 January 2018

Increased bone formation and decreased osteocalcin expression induced by reduced Twist dosage in Saethre-Chotzen syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJRE.12162

21 January 2018

Molecular silencing of Twist1 enhances osteogenic differentiation of murine mesenchymal stem cells: implication of FGFR2 signaling.

1 reference

https://api.crossref.org/works/10.1111%2FJRE.12162

21 January 2018

TWIST, a basic helix-loop-helix transcription factor, can regulate the human osteogenic lineage

1 reference

https://api.crossref.org/works/10.1111%2FJRE.12162

21 January 2018

The basic helix loop helix transcription factor Twist1 is a novel regulator of ATF4 in osteoblasts

1 reference

https://api.crossref.org/works/10.1111%2FJRE.12162

21 January 2018

Adenosine triphosphate stimulates RANKL expression through P2Y1 receptor-cyclo-oxygenase-dependent pathway in human periodontal ligament cells

1 reference

https://api.crossref.org/works/10.1111%2FJRE.12162

21 January 2018

Periodontal ligament cells under mechanical stress induce osteoclastogenesis by receptor activator of nuclear factor kappaB ligand up-regulation via prostaglandin E2 synthesis

1 reference

https://api.crossref.org/works/10.1111%2FJRE.12162

21 January 2018

Transient receptor potential vanilloid-1 regulates osteoprotegerin/RANKL homeostasis in human periodontal ligament cells

1 reference

https://api.crossref.org/works/10.1111%2FJRE.12162

21 January 2018

Discovery of novel prostaglandin analogs as potent and selective EP2/EP4 dual agonists.

1 reference

https://api.crossref.org/works/10.1111%2FJRE.12162

21 January 2018

The role of prostaglandin E receptor subtypes (EP1, EP2, EP3, and EP4) in bone resorption: an analysis using specific agonists for the respective EPs

1 reference

https://api.crossref.org/works/10.1111%2FJRE.12162

21 January 2018

E-prostanoid 2 receptors dampen mast cell degranulation via cAMP/PKA-mediated suppression of IgE-dependent signaling.

1 reference

https://api.crossref.org/works/10.1111%2FJRE.12162

21 January 2018

Prostaglandin E2 modulates IL-8 expression through formation of a multiprotein enhanceosome in human colonic epithelial cells

1 reference

https://api.crossref.org/works/10.1111%2FJRE.12162

21 January 2018

Identifiers

10.1111/JRE.12162

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/24410709

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/24410709

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50481139&oldid=1566743236"